Patterns of Primary and Secondary Therapy for Prostate Cancer in Elderly Men: Analysis of Data From CaPSURE®

Journal of Urology

Volumn 179, Issue 5, 2008, Pages 1797-1803

  Konety, Badrinath R ^a   Cowan, Janet E ^a   Carroll, Peter R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aged; antineoplastic protocols; prostate; prostatic neoplasms; therapeutics

Indexed keywords

ANDROGEN;

AGED; ARTICLE; BRACHYTHERAPY; CANCER RISK; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; ELDERLY CARE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME;

AGED; COMORBIDITY; HUMANS; MALE; PROSTATIC NEOPLASMS; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

EID: 41749108391     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.01.044     Document Type: Article

References (21)

1. Andriole G.L., Levin D.L., Crawford E.D., Gelmann E.P., Pinsky P.F., Chia D., et al., PLCO Project Team. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst 9 (2005) 433
2. de Vries S.H., Postma R., Raaijmakers R., Roemeling S., Otto S., de Koning H.J., et al. Overall and disease-specific survival of patients with screen-detected prostate cancer in the European Randomized Study of Screening for Prostate Cancer, Section Rotterdam. Eur Urol 51 (2007) 366
3. Bill-Axelson A., Holmberg L., Ruutu M., Haggman M., Andersson S.O., Bratell S., et al., Scandinavian Prostate Cancer Group Study No. 4. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977
4. Schwartz K.L., Alibhai S.M., Tomlinson G., Naglie G., and Krahn M.D. Continued undertreatment of older men with localized prostate cancer. Urology 62 (2003) 860
5. Alibhai S.M., Naglie G., Nam R., Trachtenberg J., and Krahn M.D. Do older men benefit from curative therapy of localized prostate cancer?. J Clin Oncol 21 (2003) 3318
6. Albertsen P.C., Hanley J.A., and Fine J. 20-Year outcomes following conservative management of clinically localized prostate cancer. JAMA 293 (2005) 2095
7. Johansson J.E., Andren O., Andersson S.O., Dickman P.W., Holmberg L., Magnuson A., et al. Natural history of early, localized prostate cancer. JAMA 291 (2004) 2713
8. D'Amico A.V., Whittington R., Malkowicz S.B., Schultz D., Blank K., Broderick G.A., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969
9. Cooperberg M.R., Lubeck D.P., Grossfeld G.D., Mehta S.S., and Carroll P.R. Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor. J Urol 168 (2002) 491
10. Harman S.M., Metter E.J., Tobin J.D., Pearson J., and Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86 (2001) 724
11. Tsai H.K., D'Amico A.V., Sadetsky N., Chen M.H., and Carroll P.R. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst 99 (2007) 1516
12. Fouad M.N., Mayo C.P., Funkhouser E.M., Irene Hall H., Urban D.A., and Kiefe C.I. Comorbidity independently predicted death in older prostate cancer patients, more of whom died with than from their disease. J Clin Epidemiol 57 (2004) 721
13. Newschaffer C.J., Otani K., McDonald K.M., and Penberthy L.T. Causes of death in elderly prostate cancer patients and in a comparison non prostate cancer cohort. J Natl Cancer Inst 92 (2000) 613
14. Fleshner N., Rakovitch E., and Klotz L. Differences between urologists in the United States and Canada in the approach to prostate cancer. J Urol 163 (2000) 1461
15. Hoffman R.M., Barry M.J., Stanford J.L., Hamilton A.S., Hunt W.C., and Collins M.M. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study. Am J Med 119 (2006) 418
16. Alibhai S.M.H., Leach M., Tomlinson G., and Krahn M.D. 30-Day mortality and major complications after radical prostatectomy: influence of age and comorbidity. J Natl Cancer Inst 97 (2005) 1525
17. Freedland S.J., Presti J.C., Kane C.J., Aaronson W.J., Terris M.K., Dorey F., et al. Do younger men have better biochemical outcomes after radical prostatectomy?. Urology 63 (2004) 518
18. Jani A.B., and Gratzle J. Analysis of impact of age and race on biochemical control after radiotherapy in different prostate cancer settings. Urology 66 (2005) 124
19. Wong Y.N., Mitra N., Hudes G., Localio R., Schwartz J.S., Wan F., et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 296 (2006) 2683
20. Messing E.M., Manola J., Yao J., Kiernan M., Crawford D., Wilding G., et al., Eastern Cooperative Oncology Group study EST 3886. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 7 (2006) 472
21. Stephenson A.J., Shariat S.F., Zelefsky M.J., Kattan M.W., Butler E.B., Teh B.S., et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 291 (2004) 1325